Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Healthy Volunteers (Group 1.1):
- You are 18 years of age or older, of any sex, race, or background
- You do not have lung disease (smokers and non-smokers are welcome, including those who use cigarettes, e-cigarettes, pipes, or waterpipes)
- You are able to give your own consent to participate, including a separate consent related to HIV
Volunteers with Lung Disease (Group 1.2):
- You are 18 years of age or older, of any sex, race, or background
- You have lung disease or lung disease symptoms, confirmed by at least one of the following: symptoms, a chest X-ray, breathing tests, a lung biopsy, a family history of lung disease, or a condition known to affect the lungs
- You are able to give your own consent to participate, including a separate consent related to HIV
Additional requirement for Cystic Fibrosis (CF) participants:
- You carry two copies of a specific CF gene change called ΔF508, and your lung function is at least 50% of the expected level (confirm with trial site)
Clinical Patients (Groups 2 & 3):
- You are 18 years of age or older and are being seen at one of the participating clinics
- You have evidence of lung disease through symptoms, imaging, breathing tests, biopsy, family history, a related organ condition, or a higher-than-normal level of certain immune cells in your blood called eosinophils (5% or more)
- You are willing and able to give your own consent to participate
Who may not be able to join:
Healthy Volunteers (Group 1.1):
- You have a history of chronic lung disease (such as asthma) or have had a lung illness in the past three months
- You are not considered to be in good overall health by the study doctor
- You are allergic to atropine, any local anesthetic, pilocarpine, isoproterenol, terbutaline, or aminophylline
- You are currently pregnant or breastfeeding
Volunteers with Lung Disease (Group 1.2):
- You are allergic to any of the following medications: xylocaine, lidocaine, versed, valium, atropine, pilocarpine, isoproterenol, terbutaline, aminophylline, or any local anesthetic
- The study doctor believes it would not be safe for you to undergo the study procedure (a bronchoscopy, a procedure to look inside the airways)
- You are currently pregnant or breastfeeding
Additional exclusion for CF participants:
- You have had a worsening of your CF lung symptoms within the past 8 weeks
Clinical Patients (Groups 2 & 3):
- You do not wish to give your consent to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ronald G. Crystal, M.D., Weill Medical College of Cornell University
Phone: 12127460284
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Establishing normal ranges for various parameters
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.